Searched for
FDA OFFICIAL RESIGNATION
Maharashtra minister Narhari Zirwal's viral video with transperson stirs row; Congress demands his sackingMaharashtra minister Narhari Zirwal is embroiled in controversy. A video showing him with a transperson has surfaced on social media. The o...- FDA official overseeing vaccines resigns amidst controversyA key US Food and Drug Administration official responsible for vaccines is departing at the end of April. Vinay Prasad faced criticism for ...
- Maharashtra minister Narhari Zirwal says he will resign if linked to FDA clerk briberyA scandal has erupted as an FDA clerk was caught red-handed accepting a bribe at the state secretariat. In light of these allegations, Mini...
- FDA memo on pediatric COVID-19 vaccine deaths sparks concern, expert debateA leaked FDA memo alleging at least 10 pediatric COVID-19 vaccine deaths, citing myocarditis without data, has sparked alarm. This comes as...
- FDA attributes 10 children's deaths to COVID vaccinesThe head of the FDA’s vaccine division said in an internal memo that at least 10 children died “after and because of” receiving a COVID vac...
- US government faces brain drain as 154,000 federal workers exit this weekOver 150,000 federal employees are leaving the US government this week. This marks the largest single-year exodus in nearly 80 years. Buyou...
- Controversial FDA official Dr Vinay Prasad regains Chief Medical Officer titleDr. Vinayak Prasad has been re-appointed as the FDA's Chief Medical and Scientific Officer and Director of CBER. He will advise senior offi...
- Most powerful woman in the US? MAGA firebrand Laura Loomer quietly reshaping power circles, even Trump is listeningLaura Loomer, a far-right activist once banned from social media, has become an influential, unofficial advisor to Donald Trump. Her relent...
- Dr Vinay Prasad's FDA exit in less than 3 months linked to Sarepta gene therapy controversy? Check detailsDr. Vinay Prasad, a controversial figure and critic of the FDA, resigned from his high-ranking position at the agency after less than three...
- Stocks in news: Wipro, HDFC Bank, Nazara Tech, Maruti Suzuki, Bank of BarodaAmid market volatility, promoter entities exchanged Wipro shares. Vijay Kedia invested in Advait Energy, while Bank of Baroda bid for Jet A...
- After sweeping layoffs, FDA's new plan revealed. Could it shake up food and drug safety inspections?After firing several employees, FDA is planning to hire contractors in place of fired staff. The departed staffers include people who booke...
- Stocks in news: BPCL, Adani Wilmar, Vodafone Idea, Cyient, Concord BiotechIn today's trade, shares of BPCL, Adani Wilmar, Vodafone Idea, Cyient, Concord Biotech among others will be in focus due to various news de...
- S&P, Nasdaq post big quarterly percentage drops on Trump tariff turmoilS&P 500 and Nasdaq had their worst quarters since 2022 due to concerns over Trump's economic policy and new tariffs. The S&P 500 dropped 4....
- Top US vaccine official busts RKF Jr's 'lies, misinformation' in resignation letter after being forced to quitTop FDA vaccine official Dr. Peter Marks has resigned from the department and according to multiple reports, he was forced out of his posit...
- Top vaccine official resigns from FDA, criticises Robert F. Kennedy Jr for promoting misinformation, liesFDA's top vaccine official Dr. Peter Marks resigned, criticizing U.S. health leadership for letting misinformation influence vaccination sa...
- US health dept 10,000 job cuts: When will mass layoffs begin and which depts will be the hardest hit?Robert F Kennedy Jr said the nation’s health agencies will cut 10,000 jobs from their 82,000-person workforce. Kennedy said the department ...
- Worst is over for the pharma sector. What investors should doThough short-term pressure will continue, risk-reward is getting in favour of this sector.
- Tubectomy botch-up: Probe panel formed, action against drug companyThe Chhattisgarh government has constituted a probe panel chaired by a retired judge to investigate the botched sterilisation surgeries at ...
- Ranbaxy's US subsidiary sees 5 top-level exits including boss Venkat KrishnanThe changes come within months of Sun Pharmaceutical Industries agreeing to acquire Ranbaxy from Japan’s Daiichi Sankyo under a $4 billion ...
- Ranbaxy misses May deadline to supply raw materials to AstrazenecaSupplies to Astrazeneca which could have potentially brought revenues of $40 million this year (May-December 2009) has been delayed by 2-3 ...
Load More
